DME Capital Management David Einhorn
New York, NY 21 processed 13Fs on this site, 2021 Q3 to 2026 Q3
- $3.6B
- 45 holdings
- 2026 Q3
- −9.1% QoQ
- Top 5 37.4%
AUM over time
Book
| GRBK, Green Brick Partners | Hold | 10,467,383 | $57.24 | $599M | — | — | |
| CEIX, Consol Energy | Hold | 1,640,750 | $102.03 | $167M | — | — | |
| BHF, Brighthouse Financial | Reduce −1.6% | 2,973,031 | $43.34 | $129M | −48,732 | −$27M | |
| HPQ, HP | Add +108.7% | 3,373,030 | $35.02 | $118M | +1,757,070 | +$69M | |
| KD, Kyndryl | Reduce −32.8% | 4,435,819 | $26.31 | $117M | −2,169,240 | −$27M | |
| PENN, Penn Entertainment | Add +11.9% | 5,095,340 | $19.36 | $99M | +540,630 | +$16M | |
| ODP | Add +29.9% | 2,222,470 | $39.27 | $87M | +511,890 | −$3.5M | |
| ALIT, Alight | Reduce −3.9% | 11,074,090 | $7.38 | $82M | −453,840 | −$32M | |
| THC, Tenet Healthcare | Reduce −32.9% | 597,677 | $133.03 | $80M | −292,953 | −$14M | |
| VTRS, Viatris | Add +63.8% | 7,399,810 | $10.63 | $79M | +2,882,190 | +$25M | |
| TECK, Teck Resources | Reduce −30.0% | 1,086,663 | $47.90 | $52M | −465,400 | −$19M | |
| ROIV, Roivant Sciences | Add +14.8% | 4,810,960 | $10.57 | $51M | +620,470 | +$6.7M | |
| DHT, DHT Holdings | Hold | 4,024,340 | $11.57 | $47M | — | — | |
| GLD, SPDR Gold Shares | Reduce −18.0% | 202,331 | $215.01 | $44M | −44,340 | −$7.2M | |
| PKG, Graphic Packaging | Reduce −22.3% | 1,396,130 | $26.21 | $37M | −400,000 | −$16M | |
| LBTYA, Liberty Global | Hold | 2,041,580 | $17.43 | $36M | — | — | |
| LIVN, Livanova | Reduce −51.7% | 644,269 | $54.82 | $35M | −688,535 | −$39M | |
| SDRL, Seadrill 2021 | Hold | 569,405 | $51.50 | $29M | — | — | |
| PTON, Peloton Interactive | New | 6,789,140 | $3.38 | $23M | +6,789,140 | +$23M | |
| CPRI, Capri | New | 684,770 | $33.08 | $23M | +684,770 | +$23M | |
| WFRD, Weatherford International | Reduce −44.1% | 177,339 | $122.45 | $22M | −140,138 | −$15M | |
| RSP | Hold | 182,511 | $102.72 | $19M | — | — | |
| XAR, SPDR Ser Trust | Hold | 127,557 | $139.98 | $18M | — | — | |
| IAC, IAC Inc | New | 291,460 | $46.85 | $14M | +291,460 | +$14M | |
| COYA, Coya Therapeutics | Hold | 1,274,026 | $6.06 | $7.7M | — | — | |
| LKFT, Galapagos | Add +46.9% | 234,828 | $24.78 | $5.8M | +75,000 | +$673K | |
| TEVA, Teva Pharmaceutical Industries | Hold | 324,850 | $16.25 | $5.3M | — | — | |
| GPRO, Gopro | Hold | 2,823,100 | $1.42 | $4M | — | — | |
| GDX, Vaneck ETF Trust | Hold | 111,390 | $33.93 | $3.8M | — | — | |
| SHC, Sotera Health | Hold | 300,110 | $11.87 | $3.6M | — | — | |
| OIH, Vaneck ETF Trust | Hold | 11,220 | $316.18 | $3.5M | — | — | |
| FCG, First Trust Exchange-Traded Fund | Hold | 70,830 | $26.28 | $1.9M | — | — | |
| Danimer Scientific | Hold | 2,734,580 | $0.6032 | $1.6M | — | — | |
| IVZ, Invesco Actvely Mngd Etc Fund | Hold | 117,360 | $14.05 | $1.6M | — | — | |
| TLIS, Talis Biomedical | Hold | 149,052 | $8.66 | $1.3M | — | — | |
| GANX, Gain Therapeutics | Hold | 566,130 | $1.28 | $725K | — | — | |
| NUVB, Nuvation Bio | Hold | 34,995 | $2.92 | $102K | — | — |
Exits / last held
Gone since 2024 Q1, shown at their last reported size.
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| FCNCA, First Citizens Bancshares | Exit | 0 | $1,635 | $41M | −25,160 | −$41M | |
| AER, Aercap | Exit | 0 | $86.91 | $28M | −319,050 | −$28M | |
| NPWR, Net Power | Exit | 0 | $11.39 | $22M | −1,959,280 | −$22M | |
| KVUE, Kenvue | Exit | 0 | $21.46 | $15M | −707,740 | −$15M | |
| CLVT, Clarivate | Exit | 0 | $7.43 | $2.1M | −279,560 | −$2.1M | |
| NBSE, Neubase Therapeutics | Exit | 0 | $0.4474 | $61K | −136,350 | −$61K |
Filings history
21 periods, with AUM normalized
| Period | Holds | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q3 | 45 | $3.6B | −9.1% | 13F-HR | 11/16/2026 | 000117266126005372 |
| 2026 Q2 | 46 | $3.9B | +22.5% | 13F-HR | 8/14/2026 | 000117266126003786 |
| 2026 Q1 | 45 | $3.2B | +12.0% | 13F-HR | 5/15/2026 | 000117266126002341 |
| 2025 Q4 | 41 | $2.8B | +12.1% | 13F-HR | 2/17/2026 | 000117266126001122 |
| 2025 Q3 | 37 | $2.5B | +9.3% | 13F-HR | 11/14/2025 | 000117266125005032 |
| 2025 Q2 | 34 | $2.3B | +17.8% | 13F-HR | 8/14/2025 | 000117266125003351 |
| 2025 Q1 | 33 | $2B | +1.5% | 13F-HR | 5/15/2025 | 000117266125002307 |
| 2024 Q4 | 36 | $1.9B | −19.1% | 13F-HR | 2/14/2025 | 000117266125001165 |
| 2024 Q3 | 38 | $2.4B | +17.6% | 13F-HR | 11/14/2024 | 000117266124005240 |
| 2024 Q2 | 39 | $2B | −6.5% | 13F-HR | 8/14/2024 | 000117266124003549 |
| 2024 Q1 | 42 | $2.2B | — | 13F-HR | 5/15/2024 | 000117266124002489 |
| 2023 Q4 | 40 | $2B | +16.3% | 13F-HR | 2/14/2024 | 000117266124001512 |
| 2023 Q3 | 39 | $1.8B | −17.4% | 13F-HR | 11/14/2023 | 000117266123004012 |
| 2023 Q2 | 41 | $2.1B | +15.9% | 13F-HR | 8/14/2023 | 000117266123003174 |
| 2023 Q1 | 39 | $1.8B | +27.4% | 13F-HR | 5/15/2023 | 000117266123002282 |
| 2022 Q4 | 42 | $1.4B | +2.3% | 13F-HR | 2/14/2023 | 000117266123001336 |
| 2022 Q3 | 42 | $1.4B | +9.8% | 13F-HR | 11/14/2022 | 000117266122002565 |
| 2022 Q2 | 47 | $1.3B | −18.3% | 13F-HR | 8/15/2022 | 000117266122002019 |
| 2022 Q1 | 52 | $1.6B | −10.0% | 13F-HR | 5/16/2022 | 000117266122001474 |
| 2021 Q4 | 57 | $1.7B | +17.2% | 13F-HR | 2/14/2022 | 000117266122000884 |
| 2021 Q3 | 58 | $1.5B | — | 13F-HR | 11/15/2021 | 000117266121002370 |
About
DME Capital Management
21 processed 13Fs on this site, 2021 Q3 to 2026 Q3
Further reading
As an Amazon Associate, FollowTheFilings earns from qualifying purchases.
- The Essays of Warren Buffett, 8th Ed., Warren Buffett, Lawrence A. Cunningham View on Amazon
- One Up On Wall Street (Lynch), Peter Lynch View on Amazon